Boyle Kevin S. Sr. 4
4 · Alaunos Therapeutics, Inc. · Filed Mar 17, 2023
Insider Transaction Report
Form 4
Boyle Kevin S. Sr.
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-03-15+1,800,000→ 1,800,000 totalExercise: $0.50Exp: 2033-03-14→ Common Stock (1,800,000 underlying)
Footnotes (1)
- [F1]One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from January 1, 2023, with the first vesting occuring on April 1, 2023, subject to the Reporting Person's continued service through each such date.